Qyuns Therapeutics Statistics

Total Valuation

HKG:2509 has a market cap or net worth of HKD 3.90 billion. The enterprise value is 3.37 billion.

Market Cap	3.90B
Enterprise Value	3.37B

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2509 has 224.57 million shares outstanding. The number of shares has increased by 1.94% in one year.

Current Share Class	224.57M
Shares Outstanding	224.57M
Shares Change (YoY)	+1.94%
Shares Change (QoQ)	+1.46%
Owned by Insiders (%)	4.45%
Owned by Institutions (%)	13.92%
Float	106.78M

Valuation Ratios

The trailing PE ratio is 11.11 and the forward PE ratio is 17.35.

PE Ratio	11.11
Forward PE	17.35
PS Ratio	4.35
PB Ratio	5.16
P/TBV Ratio	5.07
P/FCF Ratio	n/a
P/OCF Ratio	8.77
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	9.64
EV / Sales	3.75
EV / EBITDA	8.63
EV / EBIT	9.50
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.85.

Current Ratio	2.22
Quick Ratio	2.11
Debt / Equity	0.85
Debt / EBITDA	1.65
Debt / FCF	n/a
Interest Coverage	16.59

Financial Efficiency

Return on equity (ROE) is 68.31% and return on invested capital (ROIC) is 19.86%.

Return on Equity (ROE)	68.31%
Return on Assets (ROA)	15.43%
Return on Invested Capital (ROIC)	19.86%
Return on Capital Employed (ROCE)	29.08%
Weighted Average Cost of Capital (WACC)	12.68%
Revenue Per Employee	2.66M
Profits Per Employee	1.04M
Employee Count	337
Asset Turnover	0.62
Inventory Turnover	15.70

Taxes

Income Tax	-81,235
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +53.39% in the last 52 weeks. The beta is 1.84, so HKG:2509's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	+53.39%
50-Day Moving Average	18.78
200-Day Moving Average	21.87
Relative Strength Index (RSI)	37.76
Average Volume (20 Days)	475,314

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2509 had revenue of HKD 897.99 million and earned 349.92 million in profits. Earnings per share was 1.56.

Revenue	897.99M
Gross Profit	795.00M
Operating Income	354.91M
Pretax Income	342.05M
Net Income	349.92M
EBITDA	388.86M
EBIT	354.91M
Earnings Per Share (EPS)	1.56

Full Income Statement

Balance Sheet

The company has 1.16 billion in cash and 645.44 million in debt, giving a net cash position of 514.79 million or 2.29 per share.

Cash & Cash Equivalents	1.16B
Total Debt	645.44M
Net Cash	514.79M
Net Cash Per Share	2.29
Equity (Book Value)	755.70M
Book Value Per Share	3.42
Working Capital	682.07M

Full Balance Sheet

Cash Flow

Operating Cash Flow	444.95M
Capital Expenditures	n/a
Depreciation & Amortization	35.00M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 88.53%, with operating and profit margins of 39.52% and 38.97%.

Gross Margin	88.53%
Operating Margin	39.52%
Pretax Margin	38.09%
Profit Margin	38.97%
EBITDA Margin	43.30%
EBIT Margin	39.52%
FCF Margin	n/a

Dividends & Yields

HKG:2509 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.94%
Shareholder Yield	-1.94%
Earnings Yield	8.97%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	8